A Study of Pexa-Vec (JX-594) Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
Clinical trial NCT01171651 · COMPLETED
Trial details
- NCT number
- NCT01171651
- Sponsor
- Jennerex Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-26
- Primary completion
- 2012-09-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.